Skip to main content
SpringerLink
Log in

Cerebrovascular Disease

  • Chapter
Atlas of Vascular Disease

  • 520 Accesses

Abstract

Stroke remains the third leading cause of death in the United States, with approximately 500,000 new stroke cases reported each year [1]. The term stroke encompasses both hypoxic/ischemic brain infarction as well as a variety of hemorrhagic conditions, including hypertensive intracerebral hemorrhage, subarachnoid hemorrhage, and hemorrhage related to arteriovenous malformation rupture.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. American Heart Association: 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001.

    Google Scholar 

  2. Norris JW, Zhu CZ, Bornstein NM, Chambers BR: Vascular risks of asymptomatic carotid stenosis. Stroke 1991, 22: 1485–1490.

    Article  PubMed  CAS  Google Scholar 

  3. Jensen FE: Cerebrovascular disease. In Textbook of Vascular Medicine, edn 2. Edited by Loscalzo J, Creager MA, Dzau VJ. Boston: Little, Brown; 1996: 781–795.

    Google Scholar 

  4. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324: 71–86.

    Article  Google Scholar 

  5. Albers GW, Amarenco P, Easton JD, et al.: Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001, 119:300S–320S.

    Google Scholar 

  6. Mohr JP, Thompson JLP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl JMed 2001, 345:1444–1451.

    Google Scholar 

  7. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997, 349:1569–1581.

    Google Scholar 

  8. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997, 349:1641–1649

    Google Scholar 

  9. Wardlaw JM: Overview of Cochrane thrombolysis meta-analysis. Neurology 2001, 57: S69 - S76.

    Article  PubMed  CAS  Google Scholar 

  10. Mohler ER III, Delanty N, Rader DJ, Raps EC: Statins and cerebrovascular disease: plaque attack to prevent brain attack. Vasc Med 1999, 4: 269–272.

    Article  PubMed  Google Scholar 

  11. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325: 445–453.

    Article  Google Scholar 

  12. MRC European Carotid Surgery Trial: interim results from symptomatic patients with severe (70–99%) or mild (0–29%) carotid stenosis. Lancet 1991, 337:1235–1243.

    Google Scholar 

  13. Mayberg MR, Wilson SE, Yatsu F, et al.,for the Veterans Affairs Cooperative Studies Program 309 Trialist Group: Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991, 266:3289–3294.

    Google Scholar 

  14. Whittemore AD, Mannick JA: Principles of vascular surgery. In Textbook of Vascular Medicine, edn 2. Edited by Loscaizo J, Creager MA, Dzau VJ. Boston: Little, Brown and Co.; 1996: 675–702.

    Google Scholar 

  15. Hobson RW, Weiss DG, Fields WS, et al.: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1991, 328:221–227.

    Google Scholar 

  16. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273: 1421–1428.

    Article  Google Scholar 

  17. Roubin GS, New G, Iyer SS, et al.: Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001, 103:532–537.

    Google Scholar 

  18. Caplan LR Vertebrobasilar system syndromes. In Handbook of Clinical Neurology, vol 53, Vascular Diseases. Part I. Edited by Toole JE. Amsterdam: Elsevier; 1988: 371–408.

    Google Scholar 

  19. Cardiogenic brain embolism. Cerebral Embolism Task Force.Arch Neurol 1986, 43: 71–84.

    Google Scholar 

  20. Wolf PA, Abbott RD, Karulel WB: Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987, 147: 1561–1564.

    Article  PubMed  CAS  Google Scholar 

  21. Kannel WB, Abbott RD, Savage DD, et al.: Coronary heart disease and atrial fibrillation. Am Heart J 1983, 106: 389–396.

    Article  PubMed  CAS  Google Scholar 

  22. Preliminary report of the Stroke Prevention in Atrial Fibrillation study. N Engl J Med 1990, 322: 863–868.

    Article  Google Scholar 

  23. Stroke Prevention in Atrial Fibrillation study: final results. Circulation 1991, 84:527–539.

    Google Scholar 

  24. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 1990, 323: 1505–1511.

    Article  Google Scholar 

  25. Petersen P, Boysen G, Godtfredsen J, et al.: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet 1989, 1:175–179.

    Google Scholar 

  26. Ezekowitz MD, Bridgers SL, James KE, et al.: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992, 327:1406–1412.

    Google Scholar 

  27. Petersen P: Anticoagulant therapy for atrial fibrillation. In Atrial Fibrillation: Mechanisms and Management. Edited by Falk RH, Podrid PJ. New York: Raven Press; 1992: 307–319.

    Google Scholar 

Download references

Authors
  1. Frances E. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Creager
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Harvard Medical School, Cardiovascular Division, Simon C. Fireman Scholar in Cardiovascular Medicine, Vascular Center, Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Mark A. Creager MD (Associate Professor, Director) (Associate Professor, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jensen, F.E., Creager, M.A. (2003). Cerebrovascular Disease. In: Creager, M.A. (eds) Atlas of Vascular Disease. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4564-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4564-1_6

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-4566-5

  • Online ISBN: 978-1-4757-4564-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation